See also this year's filing and all EDGAR filings for this company.
PDF Report 0001693011_2021_Inozyme_Pharma_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001693011')"} |
Graph
Absolute values for 0001693011, Inozyme Pharma Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 150,979,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,648,000 |
| 3 | remainder_Assets | 15,736,000 |
| 4 | LiabilitiesCurrent | 9,973,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 1,287,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 10,548,000 |
| 9 | ResearchAndDevelopmentExpense | 46,493,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 617,000 |
| 13 | remainder_ComprehensiveNetIncome | -3,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 169,363,000 |
| 1 | Liabilities | 11,260,000 |
| 2 | Expenses | 57,041,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 158,103,000 |
| 5 | NetIncome | -56,424,000 |
| 6 | ComprehensiveNetIncome | -56,425,500 |
| 7 | BaseVar | 119,142,000 |
| 8 | EconomicCapitalRatio | 2.39 |
Edgar->Model Mapping
Feature Distribution
Change over Time
